MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.39
-0.89 (-6.70%)
Jul 10, 2025, 4:00 PM - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $414.46 million as of July 10, 2025.
Market Cap
414.46M
Enterprise Value
173.81M
1-Year Change
n/a
Ranking
Category
Stock Price
12.39
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $414.46M, a decrease of -18.68%. That is a compound annual growth rate of -22.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 414.46M | -32.70% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |